A Case Report on Prolonged Response with Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting

Journal of Cancer Research Updates · Published 2023-12-11 · DOI 10.30683/1929-2279.2023.12.9

Authors being retrieved — see the publisher record. https://doi.org/10.30683/1929-2279.2023.12.9

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2023

Related articles

Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence · Journal of Cancer Research Updates · 2025 · Same journal
Hypofractionated Versus Conventional Fractionated Radiotherapy for Patients with Triple Negative Breast Cancer: A Single Institution Randomized Trial · Journal of Cancer Research Updates · 2025 · Same journal
Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients · Journal of Cancer Research Updates · 2025 · Same journal
Obesity as a Risk Factor and Prognostic Indicator for B-cell Lymphoma: An Umbrella Review · Journal of Cancer Research Updates · 2025 · Same journal
Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status · Journal of Cancer Research Updates · 2026 · Same journal
Enhanced AI-Based Diagnostic Framework: Ensemble Modeling for Multi-Orientation MRI Classification of Brain Tumors and Multiple Sclerosis · Journal of Cancer Research Updates · 2025 · Same journal
Non-Performance of Cancer Screening in Peru: A Comparative Analysis between Regions Exposed and Unexposed to Ozone Layer Mini-Hole · Journal of Cancer Research Updates · 2025 · Same journal
Engagement With HPV-Related Content on Instagram: A Cross-Sectional Descriptive and Comparative Analysis of Posts Retrieved Through Four Hashtags · Journal of Cancer Research Updates · 2026 · Same journal
Genomic and Proteomic Insights into ABC Transporter-Mediated Drug Resistance in Cancer · Journal of Cancer Research Updates · 2025 · Same journal
Laetrile and Methotrexate: A Dual-Drug Approach to Inhibiting Cervical Cancer Cell Proliferation · Journal of Cancer Research Updates · 2025 · Same journal